Mosaic ImmunoEngineering (CPMV) Enterprise Value Growth (5y) (2015 - 2026)
Mosaic ImmunoEngineering (CPMV) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.72% |
| Nov 30, 2020 | 36.78% |
| Aug 31, 2020 | 34.59% |
| May 31, 2020 | 84.23% |
| Feb 29, 2020 | 29.89% |
| Nov 30, 2019 | 29.73% |
| Aug 31, 2019 | 35.25% |
| May 31, 2019 | 17.28% |
| Feb 28, 2019 | 23.77% |
| Nov 30, 2018 | 23.72% |
| Aug 31, 2018 | 22.43% |
| May 31, 2018 | 69.19% |
| Feb 28, 2018 | 19.04% |
| Nov 30, 2017 | 20.12% |
| Aug 31, 2017 | 16.05% |
| May 31, 2017 | 21.80% |
| Feb 28, 2017 | 17.20% |
| Nov 30, 2016 | 18.12% |
| Aug 31, 2016 | 22.78% |
| May 31, 2016 | 21.81% |